Correlation Between Mineralys Therapeutics, and C4 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and C4 Therapeutics, you can compare the effects of market volatilities on Mineralys Therapeutics, and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and C4 Therapeutics.
Diversification Opportunities for Mineralys Therapeutics, and C4 Therapeutics
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mineralys and CCCC is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and C4 Therapeutics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and C4 Therapeutics
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the C4 Therapeutics. In addition to that, Mineralys Therapeutics, is 1.31 times more volatile than C4 Therapeutics. It trades about -0.14 of its total potential returns per unit of risk. C4 Therapeutics is currently generating about 0.05 per unit of volatility. If you would invest 360.00 in C4 Therapeutics on November 1, 2024 and sell it today you would earn a total of 8.00 from holding C4 Therapeutics or generate 2.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. C4 Therapeutics
Performance |
| Timeline |
| Mineralys Therapeutics, |
| C4 Therapeutics |
Mineralys Therapeutics, and C4 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and C4 Therapeutics
The main advantage of trading using opposite Mineralys Therapeutics, and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.| Mineralys Therapeutics, vs. Griffon | Mineralys Therapeutics, vs. RCI Hospitality Holdings | Mineralys Therapeutics, vs. Summit Materials | Mineralys Therapeutics, vs. EastGroup Properties |
| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics | C4 Therapeutics vs. Foghorn Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |